Clinical Trials Browser

Phase 1 × Active not recruiting × Folfox protocol × Clear all

NCT06838338 2026-01-08

JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC

Phase 1 Active not recruiting

Gastrointestinal

Colorectal Neoplasms